BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 8573294)

  • 1. Lipid formulations of amphotericin B. Less toxicity but at what economic cost?
    Tollemar J; Ringdén O
    Drug Saf; 1995 Oct; 13(4):207-18. PubMed ID: 8573294
    [No Abstract]   [Full Text] [Related]  

  • 2. Amphotericin B: is a lipid-formulation gold standard feasible?
    Spellberg B; Witt MD; Beck CK
    Clin Infect Dis; 2004 Jan; 38(2):304-5; author reply 306-7. PubMed ID: 14699470
    [No Abstract]   [Full Text] [Related]  

  • 3. Lipid formulations of polyene antifungal drugs and attenuation of associated nephrotoxicity.
    Razzaque MS; Hossain MA; Ahsan N; Taguchi T
    Nephron; 2001 Nov; 89(3):251-4. PubMed ID: 11598385
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipid formulations of amphotericin B for empirical treatment of fever and neutropenia.
    Frothingham R
    Clin Infect Dis; 2002 Oct; 35(7):896-7; author reply 897-8. PubMed ID: 12228830
    [No Abstract]   [Full Text] [Related]  

  • 5. Lipid formulations of amphotericins: are you a lumper or a splitter?
    Wingard JR
    Clin Infect Dis; 2002 Oct; 35(7):891-5. PubMed ID: 12228829
    [No Abstract]   [Full Text] [Related]  

  • 6. Lipid formulations of amphotericin B.
    Jones E; Goldman M
    Cleve Clin J Med; 1998 Sep; 65(8):423-7. PubMed ID: 9769563
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term cost-effectiveness of lipid formulations of amphotericin B in the empirical therapy of invasive mycosis in a developing country.
    Tuon FF; Florencio KL; Rocha JL; Magalhaes FB
    Rev Iberoam Micol; 2017; 34(4):247-248. PubMed ID: 28743378
    [No Abstract]   [Full Text] [Related]  

  • 8. What is the current and future status of conventional amphotericin B?
    Kleinberg M
    Int J Antimicrob Agents; 2006 Jun; 27 Suppl 1():12-6. PubMed ID: 16707251
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipid amphotericin B formulations as comparators in clinical trials.
    Powers JH; Albrecht R
    Clin Infect Dis; 2004 Jan; 38(2):305-6; author reply 306-7. PubMed ID: 14699471
    [No Abstract]   [Full Text] [Related]  

  • 10. Lipid-based antifungal agents: a concise overview.
    Arikan S
    Cell Mol Biol Lett; 2002; 7(3):919-22. PubMed ID: 12378276
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ALERT: mix-ups between conventional and lipid formulations of amphotericin B can be extremely dangerous.
    Koczmara C; Richardson H; Hyland S; Lee CS; Hillebrand N
    Dynamics; 2011; 22(1):24-6. PubMed ID: 21469498
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liposomal formulations of amphotericin B: differences according to the scientific evidence.
    Azanza JR; Sádada B; Reis J
    Rev Esp Quimioter; 2015 Dec; 28(6):275-81. PubMed ID: 26621170
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liposomal and lipid-based formulations of amphotericin B.
    de Marie S
    Leukemia; 1996 Jun; 10 Suppl 2():s93-6. PubMed ID: 8649062
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Lipid formulations of amphotericin].
    Botero MC; Puentes-Herrera M; Cortés JA
    Rev Chilena Infectol; 2014 Oct; 31(5):518-27. PubMed ID: 25491449
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparative review of conventional and lipid formulations of amphotericin B.
    Robinson RF; Nahata MC
    J Clin Pharm Ther; 1999 Aug; 24(4):249-57. PubMed ID: 10475983
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipid formulations of amphotericin B: clinical efficacy and toxicities.
    Wong-Beringer A; Jacobs RA; Guglielmo BJ
    Clin Infect Dis; 1998 Sep; 27(3):603-18. PubMed ID: 9770163
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipid formulations of amphotericin B.
    Dix SP; Andriole VT
    Curr Clin Top Infect Dis; 2000; 20():1-23. PubMed ID: 10943516
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Amphotericin B: the end of an era].
    Oude Lashof AM; Kullberg BJ
    Ned Tijdschr Geneeskd; 2004 Aug; 148(34):1665-8. PubMed ID: 15453116
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amphotericin B formulated in a lipid emulsion.
    Cleary JD
    Ann Pharmacother; 1996 Apr; 30(4):409-12. PubMed ID: 8729899
    [No Abstract]   [Full Text] [Related]  

  • 20. Toxicity, stability and pharmacokinetics of amphotericin B in immunomodulator tuftsin-bearing liposomes in a murine model.
    Khan MA; Owais M
    J Antimicrob Chemother; 2006 Jul; 58(1):125-32. PubMed ID: 16709592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.